Insider Trading & Ownership of Robert Cascella
-
Location
-
Toronto
-
Summary
-
The estimated net worth of Robert Cascella is at least $2,997,850 dollars as of 01 Apr 2026. Robert Cascella is the Director of Neuronetics, Inc. and owns shares of Neuronetics, Inc. (STIM) stock worth about $1.61M. Robert Cascella is the Director of Mirion Technologies, Inc. and owns shares of Mirion Technologies, Inc. (MIR) stock worth about $797.5K. Robert Cascella is the Director of KORU Medical Systems, Inc. and owns shares of KORU Medical Systems, Inc. (KRMD) stock worth about $549.5K. Robert Cascella is the Director of CELESTICA INC and owns shares of CELESTICA INC (CLS) stock worth about $43.5K.
-
Signature
-
/s/ Thomas Adams - Attorney-in-Fact
Follow Filing Activity
Follow Robert Cascella and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Robert Cascella has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,997,850.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Neuronetics, Inc. ($1,607,333).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Robert Cascella
Insider Transactions Reported by Robert Cascella:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.